The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
D000083:Acetanilides / Q000378:metabolism; D000096:Acetone / Q000494:pharmacology; D000632:Aminopyrine / Q000378:metabolism*; D000654:Amobarbital / Q000378:metabolism*; D000814:Aniline Compounds / Q000378:metabolism*; D000818:Animals; D001711:Biotransformation / Q000187:drug effects*; D003864:Depression, Chemical; D004790:Enzyme Induction; D006221:Halothane / Q000008:administration & dosage / Q000494:pharmacology*; D006591:Hexobarbital / Q000378:metabolism*; D006900:Hydroxylation; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism*; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D010424:Pentobarbital / Q000378:metabolism*; D051381:Rats; D015049:Zoxazolamine / Q000378:metabolism
D000083:Acetanilides; D000814:Aniline Compounds; D000632:Aminopyrine; D000096:Acetone; D015049:Zoxazolamine; D006591:Hexobarbital; D010088:Oxidoreductases; D000654:Amobarbital; D010424:Pentobarbital; D006221:Halothane